561.404.4350 [email protected]

6a0133f3a4072c970b015391efe34d970b-550wiBerkeley Nutriceuticals, the maker of “natural male enhancement” supplement Enzyte, has agreed to settle an unfair and deceptive trade practices suit for $4.7m, with about 1/3 of that going to the lawyers.

To read the article, click here.

The civil suit being settled stems from the same unfair and deceptive trade practices implicated the FTC’s complaint against Berkeley.

About 

Joel B. Rothman represents clients in intellectual property infringement litigation involving patents, trademarks, copyrights, trade secrets, defamation, trade libel, unfair competition, unfair and deceptive trade practices, and commercial matters. Joel’s litigation practice also includes significant focus on electronic discovery issues such as e-discovery management and motion practice relating to e-discovery.